Literature DB >> 10760431

Changes in the use of radiotherapy in Ontario 1984-1995.

W J Mackillop1, S Zhou, P Groome, P Dixon, B J Cummings, C Hayter, L Paszat.   

Abstract

PURPOSE: To describe changes in the use of radiotherapy in the management of cancer in Ontario between January 1, 1984 and December 31, 1995.
METHODS: A retrospective review of prospectively gathered electronic records of all radiotherapy for cancer at nine provincial cancer treatment centres.
RESULTS: Over the 12 years of the study, the incidence of cancer increased by 33%. The number of curative and adjuvant courses per incident case increased by 39.3% and the number of palliative courses per incident case decreased by 15.8%. The mean number of fractions per curative and adjuvant course increased by 13%, and the mean number of fractions per palliative course decreased by 22%. The number of curative fractions per incident case increased by 63%, and the number of palliative fractions per incident case decreased by 32%. The increase in curative workload was mainly due to an increase in the incidence of prostate cancer, to an increase in the number of courses per incident case in breast and prostate cancer, and to an increase in the number of fractions per curative course in every disease group. The decrease in palliative workload was due to a decrease in the number of courses per incident case in most disease groups, and to a decrease in the number of fractions per course in most disease groups.
CONCLUSIONS: In Ontario, between 1984 and 1995, there was a large shift in workload from palliative radiotherapy to curative radiotherapy. Potential causes for this phenomenon are discussed.

Entities:  

Mesh:

Year:  1999        PMID: 10760431     DOI: 10.1016/s0360-3016(99)00010-3

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  Burgeoning career opportunities in radiation oncology.

Authors:  R G Pearcey; D B Carlow; A Padmos; K Shumak
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

2.  Palliative radiotherapy knowledge among community family physicians and nurses.

Authors:  Tanya Berrang; Rajiv Samant
Journal:  J Cancer Educ       Date:  2008       Impact factor: 2.037

Review 3.  Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers.

Authors:  Muhammad M Fareed; Rizwan Ishtiaq; Thomas J Galloway
Journal:  Curr Treat Options Oncol       Date:  2018-03-12

4.  An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy.

Authors:  C Danjoux; E Chow; A Drossos; L Holden; C Hayter; M Tsao; T Barnes; E Sinclair; M Farhadian
Journal:  Support Care Cancer       Date:  2005-04-23       Impact factor: 3.603

5.  Wait times for surgical and adjuvant radiation treatment of breast cancer in Canada and the United States: greater socioeconomic inequity in America.

Authors:  Kevin M Gorey; Isaac N Luginaah; Eric J Holowaty; Karen Y Fung; Caroline Hamm
Journal:  Clin Invest Med       Date:  2009-06-01       Impact factor: 0.825

6.  High-throughput transcriptome sequencing reveals extremely high doses of ionizing radiation-response genes in Caenorhabditis elegans.

Authors:  Youqin Xu; Lina Chen; Mengyi Liu; Yanfang Lu; Yanwei Yue; Yue Liu; Honghao Chen; Fuliang Xie; Chao Zhang
Journal:  Toxicol Res (Camb)       Date:  2019-08-06       Impact factor: 3.524

7.  Waiting times for radiation therapy in Ontario.

Authors:  Veronique Benk; Raymond Przybysz; Tom McGowan; Lawrence Paszat
Journal:  Can J Surg       Date:  2006-02       Impact factor: 2.089

8.  Waiting lists for radiation therapy: a case study.

Authors:  D P D'Souza; D K Martin; L Purdy; A Bezjak; P A Singer
Journal:  BMC Health Serv Res       Date:  2001-04-17       Impact factor: 2.655

Review 9.  Planning national radiotherapy services.

Authors:  Eduardo Rosenblatt
Journal:  Front Oncol       Date:  2014-11-25       Impact factor: 6.244

10.  How should we describe the benefits of palliative radiotherapy?

Authors:  R Samant; T Tucker
Journal:  Curr Oncol       Date:  2006-12       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.